Fremont, CA, United States of America

Fujun Zhang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Fremont, CA (US) (2011 - 2017)
  • Baltimore, MD (US) (2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Fujun Zhang in Ovarian Cancer Research

Introduction

Fujun Zhang, an accomplished inventor based in Fremont, CA, has made significant strides in the field of medical diagnostics. With four patents to his name, his work primarily focuses on developing biomarkers for ovarian cancer, enhancing the ability to identify and classify this serious illness in patients.

Latest Patents

Fujun Zhang's latest inventions include a groundbreaking protein-based biomarker related to CTAP3 that has the potential to revolutionize ovarian cancer diagnostics. His invention provides a reliable method to qualify ovarian cancer status by classifying patient samples as indicative of ovarian cancer or non-ovarian cancer. Notably, this biomarker can be detected using SELDI mass spectrometry, a technique that adds reliability to the testing process. This invention not only showcases his expertise but also emphasizes the crucial role of biomarkers in early detection and treatment success.

Career Highlights

Throughout his career, Fujun Zhang has contributed to various reputable organizations, including Vermillion Corporation and Leland Stanford Junior University. His research and innovations have been pivotal in advancing the understanding and detection of ovarian cancer, ultimately benefiting the medical community and patients alike.

Collaborations

In his professional journey, Fujun Zhang has collaborated with notable individuals such as Eric Thomas Fung and John P Cooke. These partnerships have fostered an environment of creativity and innovation, allowing for the exchange of ideas that push the boundaries of current scientific knowledge in cancer research.

Conclusion

Fujun Zhang's contributions to the field of ovarian cancer diagnostics position him as a notable inventor in the medical research community. His development of protein-based biomarkers not only advances scientific understanding but also promises enhanced patient care through more accurate diagnostics. As he continues his innovative work, the impact of his patents is sure to resonate within the medical field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…